Xeris Biopharma
5.18
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Xeris Biopharma
Xeris Biopharma Holdings, Inc., established in 2005 under Delaware law, is an innovative, self-sustaining, growth-driven biopharmaceutical company dedicated to enhancing patients' lives. The company focuses on developing and commercializing clinically meaningful therapies through a diverse portfolio of products. Leveraging its unique strengths, Xeris achieves this by offering three commercialized products alongside proprietary formulation technologies—XeriSol and XeriJect—which enable strategic partnerships and strengthen their pipeline candidates. Company website: http://www.xerispharma.com Address: 180 N. LaSalle Street Suite 1300 Chicago, Illinois 60607
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.